Recombinant interleukin-2 infusions and serum IgG subclass levels.
Aucouturier
P
P
Preud'homme
J L
JL
Fridman
W H
WH
Mathiot
C
C
D006801:Humans; D007074:Immunoglobulin G / Q000097:blood* / Q000145:classification; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D016130:Immunophenotyping; D007376:Interleukin-2 / Q000494:pharmacology* / Q000627:therapeutic use; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets; D008545:Melanoma / Q000097:blood / Q000276:immunology* / Q000628:therapy; D009363:Neoplasm Proteins / Q000097:blood* / Q000145:classification; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D007074:Immunoglobulin G; D007155:Immunologic Factors; D007376:Interleukin-2; D009363:Neoplasm Proteins; D011994:Recombinant Proteins